Grace Therapeutics, Inc. (GRCE)
1.87
+0.09
(+5.06%)
USD |
NASDAQ |
Nov 06, 10:23
Grace Therapeutics Total Assets (Quarterly) : 50.07M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.07M |
| March 31, 2026 | 77.60M |
| December 31, 2025 | 68.49M |
| September 30, 2025 | 66.58M |
| June 30, 2025 | 69.80M |
| March 31, 2025 | 81.24M |
| December 31, 2024 | 61.22M |
| September 30, 2024 | 65.35M |
| June 30, 2024 | 69.72M |
| March 31, 2024 | 73.30M |
| December 31, 2023 | 76.18M |
| September 30, 2023 | 78.21M |
| June 30, 2023 | 73.03M |
| March 31, 2023 | 79.12M |
| December 31, 2022 | 116.80M |
| September 30, 2022 | 120.91M |
| June 30, 2022 | 124.93M |
| March 31, 2022 | 128.62M |
| December 31, 2021 | 114.23M |
| September 30, 2021 | 119.80M |
| June 30, 2021 | 60.45M |
| March 31, 2021 | 62.46M |
| December 31, 2020 | 30.30M |
| September 30, 2020 | 13.83M |
| June 30, 2020 | 20.14M |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | 29.98M |
| September 30, 2019 | 28.58M |
| June 30, 2019 | 29.49M |
| March 31, 2019 | 36.28M |
| December 31, 2018 | 43.68M |
| September 30, 2018 | 15.41M |
| June 30, 2018 | 20.46M |
| March 31, 2018 | 17.81M |
| December 31, 2017 | 21.89M |
| September 30, 2017 | 15.80M |
| June 30, 2017 | 17.35M |
| February 28, 2017 | |
| November 30, 2016 | 16.06M |
| August 31, 2016 | 17.95M |
| May 31, 2016 | 19.68M |
| February 29, 2016 | 21.05M |
| November 30, 2015 | 23.23M |
| August 31, 2015 | 24.82M |
| May 31, 2015 | 28.17M |
| February 28, 2015 | 29.80M |
| November 30, 2014 | 34.21M |
| August 31, 2014 | 38.13M |
| May 31, 2014 | 40.36M |
| February 28, 2014 | 41.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.862M |
| Shareholders Equity (Quarterly) | 48.21M |
| Current Ratio | 11.47 |